Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Provention Bio Inc
(NQ:
PRVB
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Provention Bio Inc
< Previous
1
2
3
4
5
6
Next >
Tiziana Life Sciences (NASDAQ: TLSA) Announces Positive Data In Its Secondary-Progressive Multiple Sclerosis Trial, What Could This Mean For The Company?
June 15, 2023
Company Moves Ahead With Drug Development
Via
Benzinga
Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis
April 19, 2023
Tiziana Life Sciences (NASDAQ: TLSA), a London-based biotechnology company, is developing a first-in-class drug, Foralumab. Foralumab is the only fully human anti-CD3 monoclonal antibody (mAb) at the...
Via
Benzinga
Treatments For Non-Active Secondary Progressive Multiple Sclerosis Remain Scarce – Tiziana Life Sciences' (NASDAQ: TLSA) First-In-Class Foralumab Is Showing Promise
April 12, 2023
Research is being done into whether there might be treatments that tackle Multiple Sclerosis (MS) through immunosuppression and a reduction of patient neuroinflammation. Anti-CD3 monoclonal antibodies...
Via
Benzinga
Sanofi's $3B Acquisition Of Provention Bio Hits Regulatory Roadblock: FTC Requests More Information
April 11, 2023
Via
Benzinga
Is Sanofi Stock a Buy Now?
March 25, 2023
The pharma giant has outperformed the broader market over the past 12 months.
Via
The Motley Fool
Provention Bio's Earnings Outlook
March 15, 2023
Via
Benzinga
4 Analysts Have This to Say About Provention Bio
March 14, 2023
Via
Benzinga
Provention Bio's $2.9B Acquisition - A Strategic Fit For Sanofi
March 13, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Crash In March
March 22, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Stock Market Diverges Amid Bank Woes, Growth Gains; First Republic, Credit Suisse, Meta In Focus: Weekly Review
March 17, 2023
A market rally is underway, but bank stocks kept tumbling.
Via
Investor's Business Daily
Why Provention Bio Stock Skyrocketed 256% This Week
March 16, 2023
Provention Bio is currently a partner of Sanofi. It should soon become a part of the big French drugmaker.
Via
The Motley Fool
Why Shares of MacroGenics Climbed Thursday
March 16, 2023
The cancer-focused biotech delivered a strong earnings report.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2023
March 15, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023
March 14, 2023
Via
Benzinga
Top 5 Health Care Stocks That Are Ticking Portfolio Bombs
March 14, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Monday Merger Mania Just Made These 2 Biotech Stocks Big Winners
March 13, 2023
On a volatile market day, companies are still looking for smart combinations.
Via
The Motley Fool
Nasdaq Up 150 Points; Gold Rises Over 2%
March 13, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 150 points on Monday. The Dow traded up 0.59% to 32,096.68 while the NASDAQ rose 1.35% to 11,288.8. The S&P...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 13, 2023
Via
Benzinga
Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 13, 2023
Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.
Via
Benzinga
Dow Jumps 300 Points; Crude Oil Down 1%
March 13, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 300 points on Monday. The Dow traded up 0.94% to 32,210.33 while the NASDAQ rose 1.52% to 11,307.74. The S&P 500,...
Via
Benzinga
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
March 13, 2023
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
US Stocks Mostly Higher; Dow Rises 75 Points
March 13, 2023
U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 75 points on Monday. Following the market opening Monday, the Dow traded up 0.24% to 31,986.55 while the NASDAQ rose...
Via
Benzinga
Pfizer Officially Nabs Seagen For $43 Billion; Provention Soars On Sanofi Deal
March 13, 2023
Pfizer expects Seagen to add at least $10 billion to its topline in 2030.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 13, 2023
Via
Benzinga
Why Is First Republic Bank (FRC) Stock Down 61% Today?
March 13, 2023
First Republic Bank (FRC) stock is falling hard on Monday as bank stocks react to the recent drama surrounding SVB Financial (SIVB).
Via
InvestorPlace
Why Provention Bio Stock Is Rocketing Past 52-Week Highs Today
March 13, 2023
Provention Bio Inc (NASDAQ: PRVB) shares are rocketing higher Monday after Sanofi (NASDAQ: SNY) announced plans to acquire the biopharmaceutical company.
Via
Benzinga
Why Is Science 37 (SNCE) Stock Up 9% Today?
March 13, 2023
Science 37 (SNCE) stock is rising higher on Monday following news of inducement equity awards for its Metasite employees.
Via
InvestorPlace
Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket
March 13, 2023
Gainers Provention Bio, Inc. (NASDAQ: PRVB) rose 262.7% to $24.30 in pre-market trading after Sanofi agreed to acquire the company for $25.00 per share in cash, representing an equity value of...
Via
Benzinga
Why Is Provention Bio (PRVB) Stock Up 263% Today?
March 13, 2023
Provention Bio (PRVB) stock is rocketing higher on Monday following news that Sanofi (SNY) is acquiring the company for $2.9 billion.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
March 13, 2023
We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday!
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.